“Indian Hotels has been delivering very strong numbers and I think for some companies COVID actually helped them because many of these companies were very good brands and very good service companies, but they had cost issues,” says Sandip Sabharwal, asksandipsabharwal.com. I am going to pick and choose one stock that I know you are … Read more
Benchmark index Sensex closed higher by about 720 points to 60,566 on Monday. Despite the rally in the market, four stocks from the BSE Healthcare index slipped to touch their new 52-week lows. The 52-week low is the lowest price a stock has traded during the last one year. Some traders and investors use this … Read more
After relentless selling in the first half of 2022, foreign institutional investors have made a comeback to Indian equities in the recent months, and Divam Sharma of Green Portfolio sees the trend improving in the near term. “We believe that India will attract a higher weight on the MSCI EM index, and we will see … Read more
Nifty futures on the Singapore Exchange traded 40.5 points, or 0.22 per cent lower at 18,439.5, signaling that Dalal Street was headed for a negative start on Thursday. Here are a dozen stocks which may buzz the most in today’s trade: Wipro: The IT services major has reached an agreement with employee representatives on setting … Read more
New Delhi: Aurobindo Pharma on Saturday reported a 41 per cent decline in its consolidated net profit at Rs 409 crore for the second quarter ended September 30, 2022. The Hyderabad-based drug firm had posted a net profit of Rs 697 crore in the July-September period of last fiscal. Revenue from operations also declined to … Read more
Following its impressive show in Q2 business update, shares ended 5.2% higher on Friday and closed a tad below its lifetime closing high. “We believe the stock will surpass its lifetime high of Rs 2,768 and explore uncharted territory, which could take it towards Rs 3,000,” says Jatin Gohil, Technical and Derivative Research Analyst at … Read more
ET takes a look at some of the top stock recommendations by analysts. These stocks are expected to return between 11% and 26% as per analysts’ price targets. Brokerage: Price Target: Rs 290 CMP: Rs 231.4 | Upside: 25.3% The brokerage has raised its price target on the stock to Rs 290 from Rs 275, … Read more
Overseas investors are stepping up their purchases of Indian stocks and the sentiment on Dalal Steet has seen further improvement. ET has compiled a list of stock recommendations by analysts at brokerages. Based on the price targets by these brokerages, the stocks could return between 14% and 41%. Brokerage: Credit Suisse Target Price: Rs 720 … Read more
The US economy also witnessed substantial issues in its pharma market. In addition to these, manufacturing & exporting countries around the world saw heightened raw material price inflation followed by supply chain disruption. All these affected the margins of the companies deeply. Synopsis Indian pharmaceutical market flattened after the pandemic led to a massive upsurge … Read more
The companies have received the nod after inking a sub-licensing pact with Medicines Patent Pool (MPP), a UN-based public health organisation working to increase access to life-saving medicines for low- and middle-income countries. Leading drug makers Cadila Pharmaceuticals, Aurobindo Pharma and Torrent Pharmaceuticals on Thursday said they have received a licence to manufacture a generic … Read more